![]() |
市场调查报告书
商品编码
1777258
缺血性中风手术的全球市场:手术类型·产品类型·终端用户·各地区 (~2035年)Global Ischemic Stroke Surgery Market Research Report by Type of Surgery, by Product Type, by End-User, and by Region Industry Forecast till 2035 |
全球缺血性中风手术市场预计将从 2021 年的 22.9116 亿美元成长至 2035 年底的 72.6615 亿美元,复合年增长率为 8.70%。
缺血性中风手术是一种清除血栓、恢復脑血流的医疗手段,可以最大限度地减少脑损伤,提高急性缺血性中风患者的康復几率。
缺乏运动和不良的生活习惯正在推动全球缺血性中风手术市场的需求。先进手术技术和设备的引入正在改善治疗效果,越来越多的患者选择微创手术来加速復原。
然而,医疗基础设施不足和熟练医务人员的短缺阻碍了该领域的发展。然而,随着研发和投资的增加,缺血性中风手术市场正在寻找新的发展途径。
由于中风病例数量众多以及血管内血栓切除术等尖端技术的广泛应用,北美市场持续快速扩张。推动市场成长的因素包括老龄人口成长、认知度提高以及技术进步。
新的研究和血栓切除术等成功的治疗方法正在推动欧洲市场的成长。由于对医疗创新的大力支持,该地区的卒中治疗效果正在改善。
随着各国政府加大研究和医疗保健支出,亚太市场正快速扩张。在韩国、日本和印度等国家,新的治疗方法越来越普及,帮助患者復原。
在拉丁美洲、中东和非洲,中风相关疾病的发生率呈上升趋势,推动了对手术的需求。更好的医疗基础设施和健康计划支持这些地区全球市场的成长。
本报告研究了全球缺血性中风手术市场,并提供了市场定义和概述、影响市场成长的各种因素分析、市场规模趋势和预测、按各个细分市场、地区和主要国家/地区进行的细分、竞争格局以及主要公司的概况。
Global Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Industry Forecast till 2035
Industry Overview
The global ischemic stroke surgery market reached USD 2,291.16 million in 2021 and is projected to achieve USD 7,266.15 million with a CAGR of 8.70% by the end of 2035. Ischemic stroke surgery is a medical procedure used to remove blood clots and restore blood flow to the brain. It helps reduce brain damage and improves recovery chances in patients suffering from acute ischemic stroke.
An increase in physical inactivity and poor lifestyle choices is pushing the demand in the global ischemic stroke surgery market. Advanced surgical methods and tools are making treatments more effective. Patients are also choosing less invasive procedures for quicker recovery.
The presence of limited medical infrastructure and a lack of experienced professionals is slowing the progress of the global ischemic stroke surgery industry. Still, with more research and investment, the ischemic stroke surgery market is finding new paths for development.
Industry Segmentations
In terms of product type, the global market is divided into catheters, aspiration systems, guidewires, microcatheters, and others.
Based on the type of surgery, the global ischemic stroke surgery market is classified into Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, and others.
The global ischemic stroke surgery market is segmented based on the end-users, including hospitals and clinics, ambulatory surgical centers, and others.
The ischemic stroke surgery market is still expanding rapidly in North America due to a large number of stroke cases and rising utilization of cutting-edge techniques like endovascular thrombectomy. An increasing senior population, more awareness, and technological advancements are all driving market expansion.
New research and successful treatments like thrombectomy are driving the growth of the ischemic stroke surgery market in Europe. The region's stroke treatment results are improving because of strong support for healthcare innovation.
The ischemic stroke surgery market is broadening quickly in the Asia-Pacific as governments increase their spending on research and healthcare. New treatments are becoming more widely available in nations like South Korea, Japan, and India, which is helping patients recover.
Latin America, the Middle East, and Africa are experiencing a rise in stroke-related illnesses, creating a higher demand for surgery. Better medical infrastructure and health programs are helping these regions grow in the global market.
Major players in the global ischemic stroke surgery market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Stryker, Imperative Care, Penumbra, Inc., and Phenox GmbH.